l General Information |
Product Name | Myristicin from parsley leaf oil |
General description | Myristicin, a phenylpropene, is an essential oil component. It has anticholinergic and psychotropic activities. |
Synonym | 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole |
Purity | ≥85%(HPLC) | CAS Number | 607-91-0 |
Formula | C11H12O3 | Molecular Weight | 192.21 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Very Faint Yellow to Yellow oil or liquid |
l Biological Information |
Biochem/Physiol
Actions | Myristicin induces the of glutathione S-transferase and cytochrome (Cyp1a-1) in liver cells. May enhance detoxification of carcinogenic substances. Myristicin blocks cytochrome P450 monooxygenases, which detoxifies furanocoumarins. It functions as a serotonin receptor agonist and hallucinogenic agent. Myristicin stimulates glutathione S-transferase activity and might function as a chemopreventive agent. It acts as a precursor for the metabolite 3,4- methylenedioxymethamphetamine (MDMA). |
Application | Myristicin from parsley leaf oil has been used to study competitive and uncompetitive inhibition of ACP (acid phosphatase) and ALP (alkaline phosphatase). |
l Storage |
Storage temp. | 2-8°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |